Steven M Larson Selected Research

Steven M Larson Research Topics

Disease

137	Neoplasms (Cancer) 09/2023 - 01/2002
53	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2002
25	Neoplasm Metastasis (Metastasis) 11/2022 - 02/2003
18	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 11/2002
10	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 07/2003
9	Lymphoma (Lymphomas) 01/2023 - 02/2003
8	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2006
8	Neuroblastoma 01/2020 - 03/2003
6	Rectal Neoplasms (Rectal Cancer) 08/2013 - 07/2002
5	Melanoma (Melanoma, Malignant) 09/2017 - 07/2011
4	Papillary Thyroid Cancer 06/2013 - 12/2004
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2011 - 05/2005
4	Carcinoma (Carcinomatosis) 02/2011 - 07/2003
3	Glioblastoma (Glioblastoma Multiforme) 11/2015 - 10/2012
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2014 - 08/2003
3	Pain (Aches) 02/2014 - 10/2009
3	Kidney Neoplasms (Kidney Cancer) 04/2012 - 01/2003
3	Head and Neck Neoplasms (Head and Neck Cancer) 10/2008 - 05/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2003 - 01/2002
2	Peritoneal Neoplasms 01/2023 - 01/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2010
2	Hepatocellular Carcinoma (Hepatoma) 03/2018 - 02/2017
2	Disease Progression 02/2018 - 02/2003
2	Glioma (Gliomas) 01/2018 - 12/2012
2	Adenocarcinoma 01/2018 - 10/2005

Drug/Important Bio-Agent (IBA)

28	AntigensIBA 01/2021 - 09/2003
20	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 03/2004
19	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024 - 01/2002
16	Monoclonal AntibodiesIBA 11/2022 - 08/2002
16	AntibodiesIBA 01/2022 - 09/2003
14	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2005
14	Radioisotopes (Radionuclides)IBA 01/2023 - 02/2002
10	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2021 - 05/2006
9	IodineIBA 01/2023 - 10/2006
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2003
8	procaine isothiocyanate (PRIT)IBA 01/2023 - 07/2014
8	Phosphotransferases (Kinase)IBA 11/2020 - 05/2005
8	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 01/2002
8	Immunoglobulin G (IgG)IBA 01/2020 - 10/2005
7	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 10/2005
6	LigandsIBA 01/2021 - 09/2007
6	EnzymesIBA 01/2017 - 12/2005
5	RadiopharmaceuticalsIBA 09/2023 - 11/2004
5	Trastuzumab (Herceptin)FDA Link 06/2019 - 07/2003
5	Thyroglobulin FDA Link 01/2019 - 12/2004
4	omburtamab I-131IBA 11/2022 - 12/2019
4	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 12/2007
4	AcidsIBA 01/2021 - 01/2006
4	Glucose (Dextrose)FDA LinkGeneric 08/2011 - 04/2004
4	Deoxyglucose (2 Deoxy D glucose)IBA 02/2006 - 06/2002
3	Thyrotropin Alfa FDA LinkGeneric 01/2022 - 12/2004
3	Iodine-124IBA 01/2022 - 01/2008
3	lintuzumabIBA 01/2022 - 08/2002
3	IsotopesIBA 01/2021 - 08/2002
3	Peptides (Polypeptides)IBA 01/2021 - 05/2004
3	6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA 10/2020 - 09/2011
3	Chimeric Antigen ReceptorsIBA 01/2020 - 09/2007
3	Indicators and Reagents (Reagents)IBA 11/2019 - 10/2013
3	Dihydrotestosterone (Androstanolone)IBA 01/2019 - 11/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2016
3	Hormones (Hormone)IBA 01/2019 - 01/2002
3	enzalutamideIBA 02/2018 - 06/2011
3	Dextrans (Dextran)FDA Link 01/2018 - 02/2014
3	AndrogensIBA 11/2016 - 10/2009
3	IodidesIBA 11/2016 - 04/2008
3	StreptavidinIBA 07/2014 - 01/2006
3	arginine deiminaseIBA 12/2013 - 02/2012
3	ThymidineIBA 12/2013 - 09/2006
3	tanespimycin (17AAG)IBA 04/2012 - 06/2004
3	Therapeutic UsesIBA 04/2008 - 07/2006
2	LuciferasesIBA 01/2023 - 01/2022
2	Pemetrexed (MTA)FDA Link 01/2023 - 10/2006
2	human ERBB2 proteinIBA 01/2023 - 01/2018
2	VemurafenibIBA 01/2022 - 01/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 11/2015
2	Dasatinib (BMS 354825)FDA Link 11/2020 - 12/2012
2	HaptensIBA 01/2020 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2011
2	Technetium Tc 99m MedronateIBA 01/2019 - 12/2010
2	Kallikreins (Kallikrein)IBA 01/2019 - 11/2016
2	Testosterone (Sustanon)FDA Link 01/2019 - 03/2004
2	codrituzumabIBA 03/2018 - 02/2017
2	Iodine-131IBA 01/2017 - 07/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 12/2011
2	Liposomes (Liposome)IBA 12/2016 - 02/2011
2	J591 monoclonal antibodyIBA 12/2016 - 05/2014
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2016 - 05/2006
2	8H9 monoclonal antibodyIBA 12/2015 - 10/2005
2	ErbB Receptors (EGF Receptor)IBA 11/2015 - 02/2011

Therapy/Procedure

74	Therapeutics 09/2023 - 01/2002
27	Radioimmunotherapy 01/2023 - 02/2003
26	Castration 01/2022 - 07/2008
18	Drug Therapy (Chemotherapy) 08/2022 - 01/2002
13	Radiotherapy 01/2023 - 01/2002
8	Precision Medicine 01/2021 - 04/2012
5	Aftercare (After-Treatment) 01/2020 - 05/2006
4	Immunotherapy 03/2018 - 08/2002
3	Prostatectomy (Retropubic Prostatectomy) 05/2014 - 10/2004
3	Neoadjuvant Therapy 08/2013 - 04/2012
3	Thyroidectomy 06/2013 - 11/2002